Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
10%(1 trials)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
11
92%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(10)
Other(1)

Detailed Status

Completed10
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (8.3%)
N/A11 (91.7%)

Trials by Status

completed1083%
recruiting18%
unknown18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12